ANNX.NASDAQAnnexon, INC

Form 4: Annexon EVP Ted Yednock Sells 4,500 Shares Under 10b5-1 Plan

Sentiment:

SEC Form 4 Filing


Ted Yednock, EVP & Chief Innovation Officer of Annexon, Inc., sold 4,500 shares of common stock at $7.10 per share on September 19, 2024, under a pre-arranged 10b5-1 trading plan.

Summary

  • On September 19, 2024, Ted Yednock, the EVP & Chief Innovation Officer of Annexon, Inc. (ANNX), sold 4,500 shares of common stock.
  • The sale was executed at a price of $7.10 per share.
  • The transaction was conducted under a pre-arranged Rule 10b5-1 trading plan adopted on April 12, 2024.
  • Following the transaction, Yednock directly owns 71,365 shares of Annexon common stock.
  • Yednock also has indirect ownership through his spouse.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it reflects a routine transaction under a pre-existing trading plan. There is no indication of positive or negative sentiment towards the company's prospects.

Industry Context

This Form 4 filing is a routine disclosure of insider trading activity. It provides transparency into the transactions of company executives and their potential impact on investor confidence. Monitoring such filings is a standard practice in the financial industry to assess the sentiment of company insiders.

Comparison to Industry Standards

  • Form 4 filings are standard practice for publicly traded companies and their insiders.
  • The use of 10b5-1 trading plans is a common method for insiders to sell shares while avoiding accusations of trading on material non-public information.
  • The size of the transaction (4,500 shares) is relatively small compared to the total shares beneficially owned (71,365 shares), suggesting it may be part of a regular diversification strategy.

Stakeholder Impact

  • The sale of shares by an executive could be perceived negatively by some shareholders, but the existence of a 10b5-1 plan mitigates this concern.

Key Dates

DateDescription
04/12/2024Date of adoption of the Rule 10b5-1 trading plan.
09/19/2024Date of the transaction (sale of shares).
09/20/2024Date of signature of the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.